1. Hardman, J.G., Limbird, I.E., Molinoff, P.B., Ruddon, R.W., Goodman, A.G. (eds.): Goodman and Gilman’s—The Pharmacological Basis of Therapeutics, 9th edn., pp. 338–339. McGraw-Hill, New York (1992)
2. Eliopoulos, G.M., Reiszner, E., Ferraro, M.J., Moellering, R.C.: Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic. J. Antimicrob. Chemother. 20, 671–675 (1987)
3. Ritchie, D.J., Hopefl, A.W., Milligan, T.W., Byrne, J.E., Clin, M.S.: In vitro activity of clarithromycin, cefprozol, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens. Clin. Ther. 15, 107–113 (1993)
4. Hammerschlag, M.R., Qumei, K.K., Roblin, P.M.: In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 36, 1573–1574 (1992)
5. Kanfer, I., Skinner, M.F., Walker, R.B.: Analysis of macrolide antibiotics. J. Chromatogr. A 812, 255–286 (1998)